Walleye Capital’s Journey Medical DERM Stock Holding History

Walleye Capital’s Portfolio DERM Stock Details DERM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$463K	Buy	+65,462	New	+$374K	﹤0.01%	2822
2025 Q4	–	Sell	-22,554	Closed	-$161K	–	4663
2025 Q3	$161K	Buy	+22,554	New	+$164K	﹤0.01%	3451
2024 Q4	–	Sell	-23,098	Closed	-$131K	–	4973
2024 Q3	$131K	Sell	23,098 -40,481	-64%	-$208K	﹤0.01%	4271
2024 Q2	$359K	Sell	63,579 -70,817	-53%	-$291K	﹤0.01%	3815
2024 Q1	$495K	Buy	134,396 +112,196	+505%	+$488K	﹤0.01%	3207
2023 Q4	$128K	Buy	+22,200	New	+$98.9K	﹤0.01%	3930

Other funds holding DERM

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

PAIM

Punch & Associates Investment Management Edina, Minnesota $2.02B AUM 40.6% 1-Year Est. Return

PFCS

Pale Fire Capital SE Prague, Czech Republic $1.41B AUM 25.22% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return

Summit Financial Parsippany, New Jersey $9.12B AUM 27.44% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Diametric Capital Boston, Massachusetts $948M AUM 47.49% 1-Year Est. Return

Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return

Walleye Capital's DERM Position: Q2 2026 in Review

Walleye Capital opened a new position in Journey Medical (DERM) in Q2 2026: 65,462 shares worth $463K. The stake represents ﹤0.01% of the portfolio and ranks #2822 among its holdings. This is a return to the name: Walleye Capital previously reported a position in DERM as recently as Q3 2025.

Walleye Capital first reported a position in DERM in Q4 2023 and has held it in 6 quarters since. The position peaked at $495K in Q1 2024. 71 funds tracked by Wall St. Rank hold DERM as of Q2 2026.

Walleye Capital held 65,462 shares of Journey Medical worth $463K as of Q2 2026.
Journey Medical was a new Walleye Capital position in Q2 2026.
Journey Medical made up ﹤0.01% of Walleye Capital's portfolio in Q2 2026, its #2822 holding.
Walleye Capital first reported a position in Journey Medical in Q4 2023 and has held it in 6 quarters since.
Walleye Capital's Journey Medical position peaked at $495K in Q1 2024.
71 funds tracked by Wall St. Rank held Journey Medical as of Q2 2026.

Based on Walleye Capital's 13F filing for Q2 2026, filed 3 Aug 2026.